Research

The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies February 27, 2021

https://academic.oup.com/brain/article/142/6/1631/5476117

Learn more
Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/24662003/

Learn more
Investigations in GABAA receptor antibody-associated encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384834/

Learn more
GABAA receptor autoimmunity, A multicenter experienc February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501640/

Learn more
Encephalitis, severe seizures, and multifocal brain lesions, Recognizing autoimmunity to the GABAA receptor February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467683/

Learn more
Encephalitis associated with autoantibodies binding to γ-aminobutyric acid-A, γ-aminobutyric acid-B and glycine receptors: immunopathogenic mechanisms and clinical characteristics February 27, 2021

https://nnjournal.net/article/view/1359

Learn more
Psychiatric symptoms in anti glutamic acid decarboxylase associated limbic encephalitis in adults: a systematic review February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/33022299/

Learn more
Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/32221776/

Learn more
Neurologic syndromes related to anti-GAD65, Clinical and serologic response to treatment February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136051/

Learn more
Glycine receptor autoantibodies disrupt inhibitory neurotransmission February 27, 2021

https://academic.oup.com/brain/article/142/11/3398/5583666

Learn more